Primary Site >> Colorectal Cancer

Gene >> CXADR

  • 2004
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2016
  • 2017
  • 2018
Ref: A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.
PMID: 15240520
 Ref: Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver.
PMID: 17139321
Ref: Analysis of the expression of coxsackievirus and adenovirus receptor in five colon cancer cell lines.
PMID: 18081225
 Ref: Proteasome inhibitor MG-132 modifies coxsackie and adenovirus receptor expression in colon cancer cell line lovo.
PMID: 18414065
 Ref: Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
PMID: 19571664
Ref: Loss of Coxsackie and adenovirus receptor downregulates alpha-catenin expression.
PMID: 19773761
 Ref: Expression of coxsackie and adenovirus receptor distinguishes transitional cancer states in therapy-induced cellular senescence.
PMID: 21364674
 Ref: Gene therapy with recombinant adenovirus encoding endostatin encapsulated in cationic liposome in coxsackievirus and adenovirus receptor-deficient colon carcinoma murine models.
PMID: 21615297
 Ref: Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells.
PMID: 21780116
 Ref: Loss of coxsackie and adenovirus receptor expression in human colorectal cancer: A potential impact on the efficacy of adenovirus-mediated gene therapy in Chinese Han population.
PMID: 27485384
 Ref: A novel monoclonal antibody targeting coxsackie virus and adenovirus receptor inhibits tumor growth in vivo.
PMID: 28074864
Ref: The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis.
PMID: 28790840
Ref: Suppression of cancer stemness by upregulating Ligand-of-Numb protein X1 in colorectal carcinoma.
PMID: 29190716
 Ref: Heparan Sulfate Binding Coxsackievirus B3 Strain PD: A Novel Avirulent Oncolytic Agent Against Human Colorectal Carcinoma.
PMID: 29739251
Ref: Physiologically-based modeling of the pharmacokinetics of "catch-and-release" anti-carcinoembryonic antigen monoclonal antibodies in colorectal cancer xenograft mouse models.
PMID: 30321546